CJC-1295 (NO DAC) + Ipamorelin Blend Peptide Research Applications & Key Findings Growth Hormone Secretion Research Pituitary Function Studies Extensive research has examined the growth hormone secretagogue properties of the CJC-1295 + Ipamorelin combination across multiple species: Dose-dependent GH release demonstrated in rat anterior pituitary cell cultures with picomolar to micromolar peptide concentrations 2- to 10-fold increases in plasma growth hormone levels sustained for 6 days in human subjects following single CJC-1295 dose Preserved pulsatile secretion with ipamorelin addition, preventing continuous non-physiological stimulation Selective action on growth hormone release without affecting prolactin, ACTH, cortisol, FSH, or TSH levels Human trials with healthy subjects aged 21-61 years demonstrated sustained, dose-dependent increases in growth hormone and IGF-1 levels that were safe and well-tolerated at doses of 30-60 mcg/kg
Pain 162(2):561568
"Instead of suppressing appetite or slowing digestion, T2 helps increase metabolic activity while also supporting the conversion of T4 into active T3." Or Maybe GLP-1s Just Don't Work For You If you've been on GLP-1 medications for a while and haven't lost weight, it can feel especially frustrating because they seem to work for everyone else these days
Pratt E, Ma X, Liu R, et al
Dipeptidyl peptidase IV and mortality after an acute heart failure episode
But with other varieties, youll have to measure the medication and fill the injectable pen yourself